Clinical Trials Browser

Phase 1/2 × cemiplimab × Tumor-Agnostic × Clear all

NCT04706715 2025-05-31

LAG3 PET Imaging in Advanced Solid Tumors

Phase 1/2 Active not recruiting

Neoplasm Metastasis, Neoplasms